In addition to harboring activating or inactivating somatic point mutations, PKs and TFs account for a large fraction of all human fusion genes involved in cancer (COSMIC, Catalogue of Somatic Mutations in Cancer, cancer.sanger.uk4; and dbCRID, Database of Chromosome Rearrangements in Disease5). The gene discussed is ARAF; the disease is cancer.